Welcome to LookChem.com Sign In|Join Free

CAS

  • or

34923-95-0

Post Buying Request

34923-95-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

34923-95-0 Usage

Synthesis Reference(s)

Tetrahedron Letters, 39, p. 1785, 1998 DOI: 10.1016/S0040-4039(97)10864-4

Check Digit Verification of cas no

The CAS Registry Mumber 34923-95-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,4,9,2 and 3 respectively; the second part has 2 digits, 9 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 34923-95:
(7*3)+(6*4)+(5*9)+(4*2)+(3*3)+(2*9)+(1*5)=130
130 % 10 = 0
So 34923-95-0 is a valid CAS Registry Number.
InChI:InChI=1/C14H11N3/c1-2-6-11(7-3-1)17-14-12-8-4-5-9-13(12)15-10-16-14/h1-10H,(H,15,16,17)

34923-95-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name N-phenylquinazolin-4-amine

1.2 Other means of identification

Product number -
Other names 4-phenylaminoquinazoline

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:34923-95-0 SDS

34923-95-0Downstream Products

34923-95-0Relevant articles and documents

Synthesis of 4-arylaminoquinazolines via 2-amino-N-arylbenzamidines

Szczepankiewicz, Wojciech,Suwinski, Jerzy

, p. 1785 - 1786 (1998)

A new synthesis of twelve 4-arylaminoquinazolines from 2-amino-N- arylbenzamidines and formic acid is described. The entering amidines were obtained in the reaction of anthranilonitrile with 50% molar excess of aromatic amines anhydrous aluminium chloride

Catalyst and solvent switched divergent C-H functionalization: Oxidative annulation of: N -aryl substituted quinazolin-4-amine with alkynes

Meesa, Siddi Ramulu,Naikawadi, Praveen Kumar,Gugulothu, Kishan,Shiva Kumar

, p. 3032 - 3037 (2020/05/08)

The development of site-selective C-H functionalizations/annulations is one of the most challenging practices in synthetic organic chemistry particularly for substrates bearing several similarly reactive C-H bonds. Herein, we describe catalyst and solvent controlled ortho/peri site-selective oxidative annulation of C-H bonds of N-aryl substituted quinazolin-4-amines with internal alkynes. The ortho C-H selective annulation was observed using Pd-catalyst in DMF to give indole-quinazoline derivatives, while, Ru-catalyst in PEG-400 favoured the peri C-H bond annulation exclusively to furnish pyrido-quinazoline derivatives.

Facile and efficient synthesis and biological evaluation of 4-anilinoquinazoline derivatives as EGFR inhibitors

Wang, Zheng,Wu, Xue,Wang, Li,Zhang, Jiao,Liu, Jianli,Song, Zhongxing,Tang, Zhishu

supporting information, p. 2589 - 2593 (2016/05/09)

Series of 4-anilinoquinazoline derivatives were conveniently and efficiently synthesized and their antitumor activities were evaluated by MTT assay in three human cancer cell lines: H1975, HepG2 and SMMC-7721. New compounds 19a-19h were designed and synthesized to seek for powerful EGFR inhibitors and to explore whether methyl group at C-2 position of quinazoline ring has a positive effect on EGFR inhibition. All the compounds of 19a-19h were found potent against all three cell lines and five compounds (19c, 19d, and 19f-19h) were found more potent against H1975 than gefitinib. SAR studies revealed that methyl group at C-2 position of quinazoline ring could significantly improve the antitumor potency of 4-anilinoquinazolines. The same conclusion was also drawn according to the results of Western blotting analysis. Among all the tested compounds, 19g exhibited extremely potent against H1975 with an IC50 value of 0.11 μM, remarkably lower than that of gefitinib (1.23 μM). The results of western blotting analysis showed that compounds 19c and 19g could notably inhibit the expression of phosphorylated EGFR, especially 19g, almost inhibited completely.

One-pot multi component synthesis of 4-arylaminoquinazolines in the presence of sodium 30-tungstopentaphosphate

Bamoharram, Fatemeh F.,Heravi, Majid M.,Roshani, Mina,Monabati, Mahsa

experimental part, p. 511 - 514 (2011/12/16)

A new multi-component synthesis of 4-arylaminoquinazolines from the reaction of 2-aminobenzamide, orthoesters and substituted anilines in presence of catalytic amounts of sodium 30-tungstopentaphosphate, so-called Preyssler heteropolyacid, is reported. The effects of solvent, amount of catalyst and aniline and reaction time were studied. Optimum conditions for synthesis of 4-arylaminoquinazolines have been obtained.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 34923-95-0